Rexinoid therapy bypasses the differentiation block associated with acute promyelocytic leukemia harboring the PLZF/RAR alpha rearrangement.
Journal article published in 2001 by
F. Guidez,
L. Altucci,
K. Xu,
A. Rossin,
E. Wilhelm,
Dj Culligan,
E. Solomon,
H. Gronemeyer 
,
A. Zelent,
D. Grimwade
,
A. Zelent,
D. Grimwade
